Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-26 @ 12:16 PM
Ignite Modification Date:
2025-12-26 @ 12:16 PM
NCT ID:
NCT02021500
Brief Summary:
A study to collect survival data on patients previously enrolled in Abraxane pancreatic cancer study CA046.
Detailed Description:
A study to collect survival status of CA046 subjects who were know to be alive at the last report of vital status for CA046 - approximate timeframe - end of March, 2013. Once consent is given, on a quarterly basis, information on status will be collected to include:
* Vital Status
* Date of disease progression
* Subsequent anticancer therapy for pancreatic adenocarcinoma
Study:
NCT02021500
Study Brief:
Protocol Section:
NCT02021500